Viewing nowTerra Tablets 20 milligrams (Teneligliptin Hydrobromide Hydrate)
Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
Gujoo Pharmaceutical Co., Ltd.

MFDS item code 202102865 · Approved 2021.04.01 · Insurance code 669806230
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with a meal plan and exercise to help manage blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications to enhance therapeutic effects. This helps improve blood sugar management and alleviates symptoms of diabetes.
The recommended dose of this medicine, when used as monotherapy or in combination therapy, is 20 mg once daily. It may be taken with or without food. When administered in combination with a sulfonylurea, a dose reduction of the sulfonylurea may be considered to reduce the risk of hypoglycemia. No dosage adjustment is necessary in patients with renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.
This medication should not be administered to certain patients. First, patients who have allergic reactions to the active ingredient or other components should not use this product. Second, this drug is not suitable for patients with diabetic ketoacidosis, coma, or type 1 diabetes, as they require insulin treatment. Third, it is not recommended for patients with severe infections, those undergoing surgery, or individuals who have suffered serious injuries. In these cases, blood sugar should be managed with insulin. Additionally, caution is needed when using this medication in the following patients. Patients with severe liver dysfunction should use this medication carefully due to a lack of clinical experience. For patients with mild to moderate heart failure (New York Heart Association Functional Classification I–II), careful administration is also required, and it is not recommended for patients with severe heart failure (NYHA III–IV). Patients taking sulfonylureas or insulin should also exercise caution. Patients at risk for hypoglycemia, such as those with pituitary or adrenal insufficiency, poor nutritional status, irregular eating habits, those who exercise vigorously, or those who consume excessive alcohol, should be cautious as well. Patients with a history of abdominal surgery or bowel obstruction should also be careful when using this drug. It is advisable to avoid this medication in patients with risks for QT interval prolongation, such as heart disease or hypokalemia. Symptoms of pancreatitis can occur, and if severe abdominal pain or vomiting happens, immediate medical assessment is required. Using this medication may result in symptoms of hypoglycemia. Particularly, when used in conjunction with insulin or sulfonylureas, the risk of hypoglycemia may increase, necessitating careful monitoring of blood sugar status. If hypoglycemic symptoms occur, consuming sugar-containing food is necessary, and in certain drug combinations, administering glucose may be required. Gastrointestinal side effects may include constipation, abdominal distention, abdominal pain, and nausea; if symptoms are severe, consultation with a physician is recommended. If symptoms of liver dysfunction or interstitial pneumonia, or skin blisters or erosions appear, immediate medical treatment is necessary. This medication is not recommended for use during pregnancy due to unestablished safety, and careful consideration is needed while breastfeeding. Elderly patients may have reduced physical function; therefore, monitoring their condition during administration is essential. No severe side effects have been reported from overdose of this medication, but general treatment and supportive care based on the patient's condition are necessary in case of overdose. This medication is not used in children as its safety and efficacy have not been established in this population. When storing this medication, keep it out of reach of children, and avoid transferring it to other containers. There may be drug interactions when using this medication with other diabetes treatments, so consultation with a physician or pharmacist about other medications being taken is essential. Lastly, if abnormal symptoms like hypoglycemia, severe abdominal pain, skin rash, or breathing difficulties occur while taking this medication, inform healthcare personnel immediately to receive safe treatment.
Hypoglycemia, constipation, intestinal obstruction, liver function impairment, interstitial pneumonia, similar dermatitis herpetiformis, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colonic polyps, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, increased amylase, increased lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium levels, malaise, allergic rhinitis, elevated serum uric acid, peripheral edema, dyslipidemia, diarrhea, epigastric pain, hepatic steatosis, liver impairment, edema, rash, shingles, limb pain, gastritis, dizziness, upper respiratory infection, headache, tremors, weakness, hunger, fatigue, facial edema, indigestion, nausea, viral upper respiratory infection, rhinitis, cold sweats, pruritus, diabetic retinopathy, vision decline, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, cerebral infarction, hyperglycemia, liver biopsy, decreased neutrophil count, abnormal blood sugar, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, spinal disc herniation, spinal disc disorders, spinal ligament ossification, foraminal stenosis, rotator cuff syndrome, bladder mass, ureterolithiasis, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue inflammation, pneumonia, cataracts, depression, iliofemoral artery stenosis, vertigo, benign prostatic hyperplasia, knee surgery, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, vertigo, iron deficiency anemia, food allergy, vomiting, chronic gastritis, epigastric pain, abdominal pain, gastrointestinal motility disorders, gastrointestinal motility delay, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, abnormal sputum, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion, ovarian cyst, vulvar pruritus, menopausal symptoms, chest discomfort, fever, chills, generalized edema, injection site inflammation, chest pain, ureterolithiasis, dysuria, kidney cyst, nocturia, depression, anxiety disorder due to general medical conditions, ovarian cyst, vulvar pruritus, menopausal symptoms
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air entry and kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent degradation.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTeneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
Gujoo Pharmaceutical Co., Ltd.

Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
KMS Pharmaceuticals Co., Ltd.

Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
Light Phamtech Co., Ltd.

Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.